AGM 2023 Presentation

November 29, 2023November 29, 2023 Alterity Therapeutics

Post navigation

Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
XBRL 30 June 2024 filed with the SEC
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

AGM 2023 Presentation

Related Posts

Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024

Prana Maintains NASDAQ Listing

Prana AGM investor webcast details